Portfolio as on Jul 2026 · 50 equity positions
SBI BSE Sensex Next 50 ETF is a ETF scheme managed by SBI MF Mutual Fund. As of disclosures dated Jul 2026, the scheme holds 50 equity positions with an estimated equity AUM of ₹24.56 Cr. The portfolio is anchored by its top conviction bet on Divi's Laboratories, which commands a weight of 3.56%of the fund's total assets.
From a sector allocation perspective, the fund managers have concentrated their largest bet on Banks, representing 15.14% of the equity portfolio. This is followed by Finance (8.21%) and Pharmaceuticals & Biotechnology (5.60%). Under SEBI's guidelines and based on its underlying assets, this scheme carries a Very High Risk risk classification.
₹936 per unit +4.8% vs Sep '25
Last 365 days · daily NAV from AMFI · SBI BSE Sensex Next 50 ETF
Based on ~10 months of weekly NAV history from AMFI. Volatility is the annualized standard deviation of NAV returns. Sharpe ratio assumes a 6.5% risk-free rate. Past performance does not guarantee future returns — not investment advice.
Top 10 holdings make up 28.7% of the portfolio · top 5 = 16.3%.
Equity holdings only, ISIN-verified, from SBI Mutual Fund's public monthly portfolio disclosure (Jul 2026). Not investment advice.
Weight = the position as a % of this fund's portfolio. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).